제약용 글루코사민 시장, 연평균 성장률 6.5%로 13억 8천만 달러 돌파 전망 | 전망 및 동향
Pharmaceutical glucosamine is a product that meets the highest purity standards among joint health supplements and satisfies strict pharmacopoeial standards for therapeutic use. It has excellent bioavailability compared to general glucosamine products, and is gaining increasing demand among medical professionals and global consumers with high health awareness. Although it is more expensive than general products, it is gaining attention in the market where supplement regulations are strict because it can guarantee quality.
Market Overview and Regional Analysis
Asia Pacific region accounts for more than 45% of the global pharmaceutical glucosamine production, with China in particular being the production hub covering both domestic and export markets. This is due to the stability of the raw material supply chain and cost-effective production base. On the other hand, North America is the largest consumer market, with high health awareness and spending power for high-quality joint health supplements driving the market.
Europe has a strong market presence, particularly in Germany and France, due to its emphasis on scientific evidence-based product formulation and regulatory compliance . Emerging markets such as Latin America and the Middle East are also witnessing significant growth due to rising disposable income and increasing awareness of osteoarthritis.
Key Market Drivers and Opportunities
More than 300 million people worldwide suffer from osteoarthritis, and by 2030 , it is expected that about 20% of the population in developed countries will be aged 65 years or older. This demographic change, along with changes in consumer behavior that emphasize preventive healthcare, is driving market growth. Pharmaceutical glucosamine is also highly preferred by healthcare professionals who prefer supplements with proven safety and efficacy.
Product innovations such as complex formulas combined with ingredients such as chondroitin, MSM, and hyaluronic acid , and the development of vegan and allergen-free glucosamine are providing new opportunities for market expansion. In addition, personalized joint health management solutions linked to digital health are also emerging as new markets.
Market Challenges and Constraints
Pharmaceutical glucosamine market faces various challenges. Regulatory fragmentation due to differences in regulatory standards across countries, consumer confusion due to scientific debate on efficacy , and price competition from low-cost products may negatively impact the market.
Additionally, supply chain vulnerabilities for shellfish-based raw materials pose a burden to manufacturers, which may impact product safety, especially in the event of raw material price spikes or environmental issues.
Market segmentation by product type
-
Glucosamine Sulfate
-
Glucosamine Hydrochloride
-
N-Acetyl Glucosamine
Market segmentation by application
-
Health functional food
-
Pharmaceutical Formulations
-
Functional Foods and Beverages
Major Companies
-
Livzon Group
-
Zhejiang Hailisheng Pharmaceutical
-
Zhejiang Chengxin Pharmaceutical
-
Zhejiang Hisun Pharmaceutical
-
Shanxi Kangbao Bio
-
Bioiberica
-
Tianjin Shiping Pharmaceutical
-
Koyo Chemical
-
TSI Group
-
Cargill Incorporated
-
Qingdao Green-Extract Biology
-
Dalian Jinglian Group
Report Scope
This report provides a comprehensive analysis of the global and regional pharmaceutical glucosamine market from 2024 to 2032, including:
-
Sales, sales volume, profit forecasting
-
Detailed segmentation by product type and application
-
Market trends by region and country
We also provide in-depth profiles of key companies, providing:
-
Company Overview
-
Product Specifications and Portfolio
-
Production capacity and sales performance
-
Sales, unit price, profit margin
-
Strategy and Innovation Activities
This study collected the following information through a primary survey of key manufacturers, suppliers, distribution partners, and industry experts :
-
Revenue and Demand Trends
-
Product Development Status
-
Market Growth Drivers and Strategies
-
Industry barriers and risk factors
About 24chemicalresearch
Founded in 2015, 24chemicalresearch is a fast-growing research company specializing in chemical industry market information, providing services to more than 30 Fortune 500 companies to date. Based on rigorous research methodology, we analyze key factors such as government policies, technology trends, and competitive landscapes to provide our clients with practical and timely data.
-
Track factory unit production capacity
-
Real-time price monitoring
-
Techno-economic analysis
With over 10 years of experience, our professional researchers support our clients' strategic decision-making through high-quality reports, and we aim to become the most trusted source of information in the chemical and materials industries.
International: +1(332) 2424 294 | Asia: +91 9169162030
Website: https://www.24chemicalresearch.com/
LinkedIn: Follow 24chemicalresearch
Other
Related Reports:
https://chemexhubkorea.blogspot.com/2025/07/api-cagr-2025-2032.html
https://chemexhubkorea.blogspot.com/2025/07/2032_66.html
https://chemexhubkorea.blogspot.com/2025/07/2032_6.html
https://chemexhubkorea.blogspot.com/2025/07/2032_15.html
Comments
Post a Comment